Eliana Clark

Companies

• Intellia TherapeuticsEVP, Chief Technical Officer Mar 7, 2022 to now¹

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

• Intellia Therapeutics NTLA93,864 shares²$1.1M at $11.48Mar 2, 2026

As of each latest filing. The line shows shares held over time.

Recent filings

• Mar 2, 2026Sold 607 shares at $13.78 of Intellia Therapeutics²
• Mar 1, 2026Granted 7,353 shares of Intellia Therapeutics²
• Jan 5, 2026Sold 9,515 shares at $9.21 of Intellia Therapeutics³
• Jul 1, 2025Sold 1,022 shares at $9.82 of Intellia Therapeutics⁴
• Mar 4, 2025Sold 679 shares at $8.99 of Intellia Therapeutics⁵
• Mar 1, 2025Granted 32,000 shares of Intellia Therapeutics⁵
• Jan 3, 2025Sold 7,422 shares at $12.18 of Intellia Therapeutics⁶
• Jan 2, 2025Sold 556 shares at $12.03 of Intellia Therapeutics⁶
• Jul 1, 2024Sold 405 shares at $22.93 of Intellia Therapeutics⁷
• Mar 4, 2024Sold 605 shares at $32.99 of Intellia Therapeutics⁸
• Mar 1, 2024Granted 31,230 shares of Intellia Therapeutics⁸
• Jan 3, 2024Sold 4,301 shares at $29.46 of Intellia Therapeutics⁹
• Jan 3, 2024Sold 307 shares at $30.12 of Intellia Therapeutics⁹
• Jul 3, 2023Sold 360 shares at $40.51 of Intellia Therapeutics¹⁰
• Jun 20, 2023Sold 5,000 shares at $45.00 of Intellia Therapeutics¹¹
• Jun 20, 2023Exercised options 5,000 shares at $12.27 of Intellia Therapeutics¹¹
• Mar 1, 2023Granted 6,134 shares of Intellia Therapeutics¹²
• Mar 1, 2023Granted 24,539 shares of Intellia Therapeutics¹²
• Jan 4, 2023Sold 1,692 shares at $37.21 of Intellia Therapeutics¹³
• Jan 3, 2023Sold 231 shares at $34.48 of Intellia Therapeutics¹³
• Jul 1, 2022Sold 105 shares at $51.74 of Intellia Therapeutics¹³
• Mar 1, 2022Granted 10,527 shares of Intellia Therapeutics¹⁴